Fundraising Fox

Halia Therapeutics

Lehi, US · Founded 2017 · Delaware corporation

Biotech

Founders & leadership

Halia Therapeutics was founded in 2017 by David Bearss.

DB
David BearssFounder
JB
Jeffrey BurtonExecutive
MM
Mike McCullarNamed on SEC filing

Board

TP
Todd PedersenBoard director
JS
Jim SavasBoard director
GB
Gary B. SabinBoard director
JB
Jared BearssBoard director
JS
John S.K. KauweBoard director
DC
David CheckettsBoard director
MB
Mary BeckerleBoard director
PC
Preston CampbellBoard director

Reported raises · per SEC filings

Form D private placements

$23.9M disclosed across 4 rounds · 2020–2025

▶$3.5MraisedAug 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey BurtonExecutive Officer
  • David BearssDirector
  • David CheckettsDirector
  • John S.K. KauweDirector
  • Gary B. SabinDirector
  • Mary BeckerleDirector
  • Preston CampbellDirector
Offering amount
$20M
Amount sold
$3.5M
First sale
Aug 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$336.8KraisedJul 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim SavasDirector
  • David BearssExecutive Officer, Director
  • Jeffrey BurtonExecutive Officer
  • Gary B. SabinDirector
  • Todd PedersenDirector
  • Jared BearssDirector
  • John S.K. KauweDirector
Offering amount
$20M
Amount sold
$336.8K
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.2MraisedDec 2022 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey BurtonExecutive Officer
  • Jared BearssDirector
  • David BearssExecutive Officer, Director
  • John S.K. KauweDirector
  • Jim SavasDirector
Offering amount
$50M
Amount sold
$12.2M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedFeb 2021 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MIKE MCCULLARExecutive Officer, Director
  • JIM SAVASDirector
  • John S.K. KauweDirector, Promoter
  • Jared BearssExecutive Officer, Director, Promoter
  • David BearssExecutive Officer, Director, Promoter
Offering amount
$5M
Amount sold
$5M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.3MraisedOct 2020 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mike McCullarExecutive Officer, Director
  • Jim SavasDirector
  • John S.K. KauweDirector, Promoter
  • Jared BearssExecutive Officer, Director, Promoter
  • David BearssExecutive Officer, Director, Promoter
Offering amount
$15M
Amount sold
$6.3M
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summitfinance.yahoo.com · Mar 2026Halia Therapeutics - BIO Investment & Growth Summit 2026bigs.bio.org · Jan 2026Sell or Invest in Halia Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · Jun 2025Halia Therapeutics Raises $30 Million to Advance Pipeline of Anti-Inflammatory Therapeutics - Global Genesglobalgenes.org · Feb 2024Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeuticsprnewswire.com · Jan 2024

Frequently asked questions

Who founded Halia Therapeutics?
Halia Therapeutics was founded by David Bearss in 2017.
How much funding has Halia Therapeutics raised?
Halia Therapeutics has disclosed $23.9M raised across 4 rounds.
Where is Halia Therapeutics headquartered?
Halia Therapeutics is headquartered in Lehi, US.